Advantagene

Advantagene, a biotechnology company, develops and commercializes cancer immunotherapy drugs.

Advantagene, Inc., a biotechnology company, develops and commercializes cancer immunotherapy drugs. It offers Gene Mediated Cytotoxic Immunotherapy technology based drugs that are designed to work with radiation, chemotherapy, and surgery to eradicate residual tumor cells that could lead to recurrence or metastases. The company's products include ProstAtak for prostate cancer and GliAtak, a malignant glioma product, as well as a pipeline of preclinical products that target cancers at the initial removal of primary tumors. Advantagene was incorporated in 2003 and is based in Auburndale, Massachusetts.